Marketing-authorisation holder · Spain
Lainco S.A.
34 medicines in 1 country, as authorisation holder and marketer.
Medicines
Every medicine in the registers under its name, current ones first.
1–25 of 34
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ACOLORA POLVO PARA SOLUCION ORAL EN SOBRE13125 mg + 350,7 mg + 178.5 mg + 46,6 mg · Polvo para solucion oral en sobre | Macrogol, Cloreto, Hydrogen carbonate, Potassium | Spain | Authorised | 2023 |
| CARBOLIQ 200 mg/ ml SUSPENSION ORAL20 g · Suspensión oral | Carbon activo | Spain | Marketed | 2012 |
| CARBON ULTRA ADSORBENTE LAINCO 125 mg/ml GRANULADO PARA SUSPENSIÓN ORAL25 g · Granulado para suspensión oral | Carbon adsorbente | Spain | Marketed | 1997 |
| CLISTERAN 450 MG/45MG SOLUCION RECTAL450 mg + 45 mg · Solución rectal | Citrato sodio, Laurilsulfoacetato | Spain | Marketed | 2001 |
| CLORHEXLAN 20 MG/ML SOLUCION PARA PULVERIZACION CUTANEA105,82 mg/ml · Solución para pulverización cutánea | Chlorhexidine | Spain | Marketed | 2023 |
| CURADONA 100 MG/G GEL100,00 mg · GEL | Povidona iodada | Spain | Marketed | 2018 |
| CURADONA 100 MG/ML SOLUCIÓN CUTÁNEA10 g · Solución cutánea | Povidona iodada | Spain | Marketed | 2000 |
| CURADONA 100 MG/ML SOLUCION VAGINAL105 mg · Solución vaginal | Povidona iodada | Spain | Marketed | 2018 |
| CURADONA SCRUB 75 MG/ML SOLUCIÓN CUTÁNEA7,5 % p/v · Solución cutánea | Povidona iodada | Spain | Marketed | 2007 |
| CURADONA UNIDOSIS 100 MG/ML SOLUCIÓN CUTÁNEA10 g · Solución cutánea | Povidona iodada | Spain | Marketed | 2005 |
| EMULIQUEN LAXANTE 478,26 mg/ml + 0,3 mg/ml EMULSION ORAL2390 mg + 1,5 mg · Emulsión oral | Mineral oil, Picosulfate | Spain | Marketed | 1934 |
| EMULIQUEN LAXANTE 7.173,9 mg/4,5 mg EMULSION ORAL EN SOBRES7173,9 mg + 4,5 mg · Emulsión oral | Mineral oil, Picosulfate | Spain | Marketed | 2001 |
| EMULIQUEN SIMPLE 478,26 mg/ml EMULSION ORAL7173,9 mg · Emulsión oral | Mineral oil | Spain | Marketed | 1934 |
| EMULIQUEN SIMPLE 7.173,9 mg EMULSION ORAL EN SOBRES7173,9 mg · Emulsión oral | Mineral oil | Spain | Marketed | 1998 |
| EVACUANTE LAINCO SIMPLE POLVO PARA SOLUCIÓN ORAL15,088 (17,75) g + 60,350 (71) g + 90,650 (106,6) g + 0,366 (17,75) g + 1,462 (71) g + 2,190 (106,6) g + 1,422 (17,75) g + 5,689 (71) g + 8,520 (106,6) g + 0,187 (17,75) g + 0,748 (71) g + 1,120 (106,6) g + 0,421 (17,75) g + 1,683 (71) g + 2,520 (106,6) g · Polvo para solución oral | Polietilenglicol, Cloreto, Sodio sulfato, Potassium, Bicarbonate | Spain | Marketed | 1999 |
| EZOR GOTAS ORALES EN SOLUCION7,5 mg · Gotas orales en solución | Picosulfate | Spain | Marketed | 2001 |
| FOSLAINCO 10,8/24,4 g SOLUCION ORAL24,4 g + 10,8 g · Solución oral | Monosodio, Disodio dodecahidrato | Spain | Marketed | 2000 |
| GOLAX 10 G SOLUCION ORAL EN SOBRE19,95 g · Solucion oral en sobre | Lactulosa,liquida | Spain | Authorised | 2025 |
| GOLAX 667 MG/ML SOLUCION ORAL1,33 g/ml · Solución oral | Lactulosa,liquida | Spain | Authorised | 2025 |
| KANOVA ADULTOS 6,75g SOLUCION RECTAL6,75 g · Solución rectal | Glycerine | Spain | Marketed | 2010 |
| KANOVA NIÑOS 2,25g SOLUCION RECTAL2,25 g · Solución rectal | Glycerine | Spain | Marketed | 2010 |
| LACTULOSA LAINCO 10 g SOLUCION ORAL EN SOBRES EFG0,67 g · Solución oral | Lactulose | Spain | Marketed | 2007 |
| LACTULOSA LAINCO 3,33 g/5 ml SOLUCION ORAL EFG0,67 g · Solución oral | Lactulose | Spain | Marketed | 2007 |
| LAINEMA 14/3 g/100 ml SOLUCION RECTAL EFG139 mg + 32 mg · Solución rectal | Dihidrogenofosfato, Disodio | Spain | Marketed | 2009 |
| LAIRESP 0,5 MG/ML SOLUCION PARA PULVERIZACION NASAL65 µg · Solucion para pulverizacion nasal | Oxymetazoline | Spain | Marketed | 2012 |